Approximately 14 Days

Ganirelix acetate is a gonadotropin-releasing hormone (GnRH) antagonist used to suppress ovarian function before surgery. Typically, patients receive 120 mg of ganirelix acetate administered subcutaneously every other day, starting 14 days before the planned surgery. This regimen effectively reduces estrogen levels, minimizing the risk of post-operative complications like ovarian hyperstimulation syndrome. Monitoring is crucial to assess its effectiveness.

Ganirelix Dosage and Timing

Dosage: 120 mg subcutaneously every other day. Start Date: 14 days prior to surgery. Duration: Treatment continues until 24-48 hours before surgery. Important Note: Individual responses can vary, and adjustments to the dosage or timing may be necessary based on monitoring results.

Comparison of Suppression Methods

Method	Duration	Estimated Cost
Ganirelix Acetate	14-28 days	$800 - $1500
Leuprolide Acetate	21 days	$600 - $1200
GnRH Agonist Pulse Protocol	7-14 days	$700 - $1400

Monitoring and Considerations

• Estrogen Levels: Regular blood tests are essential to monitor estrogen levels and ensure adequate suppression.
• Progesterone Levels: Monitoring progesterone levels is also important, particularly closer to the surgery date.
• Patient Response: Individual responses to ganirelix can vary. Close observation and potential adjustments to the treatment plan are necessary.
• Surgery Timing: The timing of surgery should be carefully coordinated with the ganirelix treatment to avoid premature ovarian stimulation.